CH606000A5 - - Google Patents

Info

Publication number
CH606000A5
CH606000A5 CH1815973A CH1815973A CH606000A5 CH 606000 A5 CH606000 A5 CH 606000A5 CH 1815973 A CH1815973 A CH 1815973A CH 1815973 A CH1815973 A CH 1815973A CH 606000 A5 CH606000 A5 CH 606000A5
Authority
CH
Switzerland
Application number
CH1815973A
Inventor
Burgon Grant Christensen
Ronald William Ratcliffe
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH606000A5 publication Critical patent/CH606000A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
CH1815973A 1972-12-29 1973-12-27 CH606000A5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31994672A 1972-12-29 1972-12-29
US05/410,831 US4032521A (en) 1972-12-29 1973-11-08 Cephalosporin phosphonic acid, sulfonic acid and sulfonamide compounds

Publications (1)

Publication Number Publication Date
CH606000A5 true CH606000A5 (da) 1978-10-13

Family

ID=26982211

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1815973A CH606000A5 (da) 1972-12-29 1973-12-27

Country Status (7)

Country Link
US (1) US4032521A (da)
JP (1) JPS4994697A (da)
CH (1) CH606000A5 (da)
DE (1) DE2364735A1 (da)
FR (1) FR2212138B1 (da)
GB (1) GB1449290A (da)
NL (1) NL7317046A (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5760345B2 (da) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4117126A (en) * 1975-04-03 1978-09-26 Sumitomo Chemical Company, Ltd. 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4031077A (en) * 1975-10-06 1977-06-21 Pfizer Inc. Antibacterial 3-phosphono penams
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
US4109084A (en) * 1976-12-08 1978-08-22 E. R. Squibb & Sons, Inc. Thiooxime cephalosporin derivatives
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
IL86941A (en) * 1987-07-10 1993-07-08 Gist Brocades Nv Process for the preparation of cephem compounds and some new cephalosporin derivatives prepared by this process
US5731299A (en) * 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
CA2107644A1 (en) * 1992-10-28 1994-04-29 David R. Magnin .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
US5470845A (en) * 1992-10-28 1995-11-28 Bristol-Myers Squibb Company Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
US5447922A (en) * 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
CA2833121A1 (en) 2011-04-28 2012-11-01 Shionogi & Co., Ltd. Novel cephem compound having catechol or pseudo-catechol structure
CN103619853A (zh) * 2011-06-27 2014-03-05 盐野义制药株式会社 具有吡啶鎓基的头孢烯化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3801567A (en) * 1969-07-08 1974-04-02 Ciba Geigy Corp Process for the manufacture of 6-amino-3-carbonylamino-penam compounds
US3856785A (en) * 1972-07-24 1974-12-24 Squibb & Sons Inc Cephalosporin esters
US3966719A (en) * 1973-10-17 1976-06-29 Pfizer Inc. 4-(Tetrazol-5-yl)-Δ3 -cephem compounds

Also Published As

Publication number Publication date
US4032521A (en) 1977-06-28
DE2364735A1 (de) 1974-07-04
GB1449290A (en) 1976-09-15
FR2212138B1 (da) 1976-05-14
NL7317046A (da) 1974-07-02
JPS4994697A (da) 1974-09-09
FR2212138A1 (da) 1974-07-26

Similar Documents

Publication Publication Date Title
JPS5247888B2 (da)
FR2212138B1 (da)
JPS4989494A (da)
AU473280B2 (da)
JPS49672A (da)
JPS4910907A (da)
JPS5422045B2 (da)
JPS5424663B2 (da)
JPS4936994A (da)
JPS5223095Y2 (da)
JPS5435460B2 (da)
JPS5742938B2 (da)
JPS528870B2 (da)
JPS5231729B2 (da)
JPS4883429A (da)
JPS48100938U (da)
JPS4927258A (da)
NO744610L (da)
CH590917A5 (da)
CH569571A5 (da)
CH596324A5 (da)
CH567592A5 (da)
CH566631A5 (da)
CH590850A5 (da)
CH590818A5 (da)

Legal Events

Date Code Title Description
PL Patent ceased